CAT No: CP25586
CAS No:204251-86-5
Synonyms/Alias:204251-86-5;(R)-4-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-5-(allyloxy)-5-oxopentanoic acid;Fmoc-D-Glu-OAll;(4R)-4-(9H-fluoren-9-ylmethoxycarbonylamino)-5-oxo-5-prop-2-enoxypentanoic acid;(R)-4-((((9H-Fluoren-9-yl)methoxy)carbonyl)-amino)-5-(allyloxy)-5-oxopentanoic acid;MFCD01074691;DTXSID80679798;(4R)-4-({[(9H-fluoren-9-yl)methoxy]carbonyl}amino)-5-oxo-5-(prop-2-en-1-yloxy)pentanoic acid;AKOS016843653;DS-5128;FD21375;(R)-4-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-5-(allyloxy)-5-oxopentanoicacid;CS-0157986;(R)-4-(Fmoc-amino)-5-(allyloxy)-5-oxopentanoic acid;S-204251-86-5;N-alpha-(9-Fluorenylmethyloxycarbonyl)-D-glutamic-acid-alpha allyl ester;N-alpha-(9-Fluorenylmethyloxycarbonyl)-D-glutamic-acid-alpha allyl ester (Fmoc-D-Glu-OAll);(4R)-4-({[(9H-Fluoren-9-yl)methoxy]carbonyl}amino)-5-oxo-5-[(prop-2-en-1-yl)oxy]pentanoic acid;(4R)-4-{[(9H-FLUOREN-9-YLMETHOXY)CARBONYL]AMINO}-5-OXO-5-(PROP-2-EN-1-YLOXY)PENTANOIC ACID;
Chemical Name:N-alpha-(9-Fluorenylmethyloxycarbonyl)-D-glutamic-acid-alpha allyl ester
1. Emerging applications of nanotechnology for diagnosis and therapy of disease: a review
5. Implications of ligand-receptor binding kinetics on GLP-1R signalling
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More